Valeo Pharma Inc.
VPHIF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,192 | -$7,811 | -$6,872 | -$9,245 |
| Dep. & Amort. | $626 | $685 | $652 | $751 |
| Deferred Tax | $0 | $0 | $3,797 | $2,920 |
| Stock-Based Comp. | $28 | $47 | $194 | $109 |
| Change in WC | $4,262 | $1,642 | $6,466 | $4,063 |
| Other Non-Cash | $3,727 | $1,906 | -$2,766 | -$1,268 |
| Operating Cash Flow | $451 | -$3,531 | $1,471 | -$2,670 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$40 | -$50 | -$5,029 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $1,327 | $275 | $0 |
| Investing Cash Flow | $0 | $1,287 | $225 | -$5,029 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$62 | -$624 | -$211 | $1,430 |
| Stock Issued | $0 | $0 | $0 | $3,920 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$186 | $0 | $671 | -$297 |
| Financing Cash Flow | -$248 | -$624 | $460 | $5,053 |
| Forex Effect | $32 | $173 | -$233 | $372 |
| Net Chg. in Cash | $235 | -$2,695 | $2,083 | -$2,274 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,890 | $9,585 | $7,502 | $9,776 |
| End Cash | $7,125 | $6,890 | $9,585 | $7,502 |
| Free Cash Flow | $451 | -$3,571 | $1,421 | -$7,699 |